Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Guo-Jun Zhao is active.

Publication


Featured researches published by Guo-Jun Zhao.


Molecular Medicine | 2012

The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Guo-Jun Zhao; Kai Yin; Yu-chang Fu; Chao-Ke Tang

Reverse cholesterol transport (RCT) has been characterized as a crucial step for antiatherosclerosis, which is initiated by ATP-binding cassette A1 (ABCA1) to mediate the efflux of cellular phospholipids and cholesterol to lipid-free apolipoprotein A-I (apoA-I). However, the mechanisms underlying apoA-I/ABCA1 interaction to lead to the lipidation of apoA-I are poorly understood. There are several models proposed for the interaction of apoA-I with ABCA1 as well as the lipidation of apoA-I mediated by ABCA1. ApoA-I increases the levels of ABCA1 protein markedly. In turn, ABCA1 can stabilize apoA-I. The interaction of apoA-I with ABCA1 could activate signaling molecules that modulate posttranslational ABCA1 activity or lipid transport activity. The key signaling molecules in these processes include protein kinase A (PKA), protein kinase C (PKC), Janus kinase 2 (JAK2), Rho GTPases and Ca2+, and many factors also could influence the interaction of apoA-I with ABCA1. This review will summarize these mechanisms for the apoA-I interaction with ABCA1 as well as the signal transduction pathways involved in these processes.


Circulation | 2018

Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages

Min Zhang; Guo-Jun Zhao; Kai Yin; Xiao-Dan Xia; Duo Gong; Zhen-Wang Zhao; Ling-Yan Chen; Xi-Long Zheng; Xiao-Er Tang; Chao-Ke Tang

BACKGROUND It has previously been demonstrated that apolipoprotein A-1 (apoA-1) binding protein (AIBP) promotes apoA-1 binding to ATP-binding cassette transporter A1 (ABCA1) and prevents ABCA1 protein degradation so as to inhibit foam cell formation. Because apoA-1 inhibits inflammatory signaling pathways, whether AIBP has an inhibitory effect on inflammatory signaling pathways in THP-1-derived macrophages is investigated.Methods and Results:Analysis of inflammation-related gene expression indicated that AIBP decreased lipopolysaccharide (LPS)-mediated macrophage inflammation. AIBP significantly prevented NF-κB nuclear translocation. Further, AIBP prevented the activation of mitogen-activated protein kinases (MAPKs), including p38 MAPK, extracellular-signal regulated kinase and c-Jun N-terminal kinase. AIBP decreased MyD88 expression at both mRNA and protein levels, but did not have any effect on TLR4 expression. Moreover, treatment with both AIBP and apoA-1 decreased the abundance of TLR4 in the lipid raft fraction. AIBP lacking 115-123 amino acids (∆115-123), however, did not have such effects as described for intact AIBP. In addition, knockdown of ABCA1 inhibited the effects of AIBP on inflammatory factor secretion. CONCLUSIONS These results suggest that AIBP inhibits inflammatory signaling pathways through binding to apoA-1 and stabilizing ABCA1, and subsequent alteration of lipid rafts and TLR4 in the cell membrane.


Atherosclerosis | 2017

Proprotein convertase furin/PCSK3 and atherosclerosis: New insights and potential therapeutic targets

Kun Ren; Ting Jiang; Xi-Long Zheng; Guo-Jun Zhao

Furin, a member of the mammalian proprotein convertases family, can promote the proteolytic maturation of proproteins. It is known that furin is predominantly present in certain cell types of human atherosclerotic lesions and neointima in animal models, including vascular smooth muscle cells, endothelial cells and mononuclear inflammatory cells. Evidence suggests that furin participates in the initiation and progression of atherosclerosis through regulation of lipid and cholesterol metabolism, inflammatory response, blood pressure and the formation of atherosclerotic lesions. This review provides a panorama of the roles of furin in atherosclerosis and the insights into the prevention and treatment of atherosclerosis and cardiovascular disease.


Frontiers in Immunology | 2018

Transcriptional Regulation of Macrophages Polarization by MicroRNAs

Heng Li; Ting Jiang; Meng-Qi Li; Xi-Long Zheng; Guo-Jun Zhao

Diversity and plasticity are the hallmarks of cells from the monocyte–macrophage lineage. Macrophages undergo classical M1 or alternative M2 activation in response to the microenvironment signals. Several transcription factors, such as peroxisome proliferator-activated receptors, signal transducers and activators of transcription, CCAAT-enhancer-binding proteins, interferon regulatory factors, Kruppel-like factors, GATA binding protein 3, nuclear transcription factor-κB, and c-MYC, were found to promote the expression of specific genes, which dictate the functional polarization of macrophages. Importantly, these transcription factors can be regulated by microRNAs (miRNAs), a group of small non-coding RNAs, which regulate gene expression through translation repression or mRNA degradation. Recent studies have also revealed that miRNAs control macrophage polarization by regulating transcription factors in response to the microenvironment signals. This review will summarize recent progress of miRNAs in the transcriptional regulation of macrophage polarization and provide the insights into the development of macrophage-centered diagnostic and therapeutic strategies.


European Journal of Pharmacology | 2017

Hsp27 promotes ABCA1 expression and cholesterol efflux through the PI3K/PKCζ/Sp1 pathway in THP-1 macrophages

Hai-Jun Kuang; Guo-Jun Zhao; Wu-Jun Chen; Min Zhang; Gao-Feng Zeng; Xi-Long Zheng; Chao-Ke Tang

ABSTRACT Heat shock protein 27 (Hsp27) is a putative biomarker and therapeutic target in atherosclerosis. This study was to explore the potential mechanisms underlying Hsp27 effects on ATP‐binding cassette transporter A1 (ABCA1) expression and cellular cholesterol efflux. THP‐1 macrophage‐derived foam cells were infected with adenovirus to express wild‐type Hsp27, hyper‐phosphorylated Hsp27 mimic (3D Hsp27), antisense Hsp27 or hypo‐phosphorylated Hsp27 mimic (3A Hsp27). Wild‐type and 3D Hsp27 were found to up‐regulate ABCA1 mRNA and protein expression and increase cholesterol efflux from cells. Expression of antisense or 3A Hsp27 suppressed the expression of ABCA1 and cholesterol efflux. Furthermore, over‐expression of wild‐type and 3D Hsp27 significantly increased the levels of phosphorylated specificity protein 1 (Sp1), protein kinase C &zgr; (PKC&zgr;) and phosphatidylinositol 3‐kinase (PI3K). In addition, the up‐regulation of ABCA1 expression and cholesterol efflux induced by 3D Hsp27 was suppressed by inhibition of Sp1, PKC&zgr; and PI3K with specific kinase inhibitors. Taken together, our results revealed that Hsp27 may up‐regulate the expression of ABCA1 and promotes cholesterol efflux through activation of the PI3K/PKC&zgr;/Sp1 signal pathway in THP‐1 macrophage‐derived foam cells. Our findings may partly explain the mechanisms underlying the anti‐atherogenic effect of Hsp27.


Molecular Medicine | 2018

MicroRNA-296: a promising target in the pathogenesis of atherosclerosis?

Heng Li; Xin-Ping Ouyang; Ting Jiang; Xi-Long Zheng; Ping-Ping He; Guo-Jun Zhao

Atherosclerosis has been recognized as an inflammatory disease involving the vascular wall. MicroRNAs are a group of small noncoding RNAs to regulate gene expression at the transcriptional level through mRNA degradation or translation repression. Recent studies suggest that miR-296 may play crucial roles in the regulation of angiogenesis, inflammatory response, cholesterol metabolism, hypertension, cellular proliferation and apoptosis. In this review, we primarily discussed the molecular targets of miR-296 involved in the development of atherosclerosis, which may provide a basis for future investigation and a better understanding of the biological functions of miR-296 in atherosclerosis.


International Journal of Cardiology | 2017

TG and VLDL cholesterol activate NLRP1 inflammasome by Nuclear Factor-κB in endothelial cells

Yanjun Pan; Yan Wang; Jianqiang Xu; Jian-Feng Wu; Qingyong Chen; Gao-Feng Zeng; Guo-Jun Zhao


Atherosclerosis | 2018

MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post-transcriptional repression of scavenger receptor class B type I

Kun Ren; Xiao Zhu; Zhi Zheng; Zhong-Cheng Mo; Xiao-Shan Peng; Yong-Zhi Zeng; Han-Xiao Ou; Qing-Hai Zhang; Hui-Zhou Qi; Guo-Jun Zhao; Guang-Hui Yi


Atherosclerosis | 2018

AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE−/− mice

Min Zhang; Guo-Jun Zhao; Feng Yao; Xiao-Dan Xia; Duo Gong; Zhen-Wang Zhao; Ling-Yan Chen; Xi-Long Zheng; Xiao-Er Tang; Chao-Ke Tang


International Journal of Cardiology | 2017

Statin protects the heart against ischemia-reperfusion injury via inhibition of the NLRP3 inflammasome

Si-yang Yu; Liang Tang; Guo-Jun Zhao; Shenghua Zhou

Collaboration


Dive into the Guo-Jun Zhao's collaboration.

Top Co-Authors

Avatar

Ting Jiang

Guilin Medical University

View shared research outputs
Top Co-Authors

Avatar

Kun Ren

University of South China

View shared research outputs
Top Co-Authors

Avatar

Chao-Ke Tang

University of South China

View shared research outputs
Top Co-Authors

Avatar

Heng Li

Guilin Medical University

View shared research outputs
Top Co-Authors

Avatar

Ling-Yan Chen

University of South China

View shared research outputs
Top Co-Authors

Avatar

Min Zhang

University of South China

View shared research outputs
Top Co-Authors

Avatar

Xiao-Dan Xia

University of South China

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Zhen-Wang Zhao

University of South China

View shared research outputs
Top Co-Authors

Avatar

Duo Gong

University of South China

View shared research outputs
Researchain Logo
Decentralizing Knowledge